Evidence supporting the use of: Triphala
For the health condition: Crohn's Disease

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Traditional
Rating (out of 5): 2

Triphala is a traditional Ayurvedic herbal formulation composed of three fruits: Amalaki (Emblica officinalis), Bibhitaki (Terminalia bellirica), and Haritaki (Terminalia chebula). In Ayurveda, triphala is celebrated for its purported ability to balance the digestive system, gently detoxify the gut, and support overall gastrointestinal health. Its use in the context of Crohn’s disease is primarily based on these broad digestive benefits, as described in classical Ayurvedic texts and by modern Ayurvedic practitioners. There is anecdotal and traditional reporting that triphala may help soothe intestinal inflammation, improve bowel regularity, and enhance mucosal healing, which are relevant to Crohn’s disease symptoms. However, direct scientific studies specifically examining the effects of triphala on Crohn's disease in humans are lacking. Some preclinical and animal studies suggest that triphala possesses anti-inflammatory, antioxidant, and immunomodulatory properties, which theoretically could be beneficial for inflammatory bowel diseases. Nevertheless, the evidence is indirect and not robust enough to support its efficacy in Crohn's disease specifically. Clinical trials in humans with Crohn’s disease are either absent or limited to small pilot studies with inconclusive results. In summary, triphala’s use for Crohn’s disease is rooted in traditional medicine rather than scientific validation. While its general gut-supporting effects are well-regarded in Ayurveda, modern clinical evidence is insufficient to recommend it as a primary therapy for Crohn’s disease.

More about triphala
More about Crohn's Disease